Bernard Masquelier

4.8k total citations
85 papers, 2.3k citations indexed

About

Bernard Masquelier is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Bernard Masquelier has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 79 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Bernard Masquelier's work include HIV Research and Treatment (79 papers), HIV/AIDS drug development and treatment (74 papers) and HIV/AIDS Research and Interventions (61 papers). Bernard Masquelier is often cited by papers focused on HIV Research and Treatment (79 papers), HIV/AIDS drug development and treatment (74 papers) and HIV/AIDS Research and Interventions (61 papers). Bernard Masquelier collaborates with scholars based in France, Italy and Germany. Bernard Masquelier's co-authors include Hervé Fleury, Diane Descamps, Marie‐Laure Chaix, Françoise Brun‐Vézinet, D. Neau, Vincent Cálvez, Jacques Izopet, François Dabis, Rodolphe Thiébaut and Christine Rouzioux and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Bernard Masquelier

85 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Masquelier France 30 2.1k 1.9k 399 181 140 85 2.3k
J. M. A. Lange Netherlands 14 1.2k 0.6× 1.3k 0.7× 343 0.9× 101 0.6× 154 1.1× 22 1.7k
Diane Descamps France 35 3.3k 1.6× 3.1k 1.7× 693 1.7× 283 1.6× 223 1.6× 140 3.8k
Leslie Jonas United States 10 1.7k 0.8× 1.7k 0.9× 486 1.2× 142 0.8× 234 1.7× 11 2.2k
S Cassol Canada 16 913 0.4× 872 0.5× 428 1.1× 153 0.8× 69 0.5× 27 1.4k
Laurence Morand‐Joubert France 26 1.4k 0.7× 1.4k 0.7× 543 1.4× 147 0.8× 125 0.9× 96 2.0k
Gilles Collin France 24 1.3k 0.6× 1.2k 0.6× 373 0.9× 209 1.2× 68 0.5× 60 1.6k
Alain Lafeuillade France 24 1.1k 0.5× 1.2k 0.6× 368 0.9× 89 0.5× 280 2.0× 89 1.7k
Sidonie Lambert-Niclot France 21 1.1k 0.5× 1.1k 0.6× 241 0.6× 74 0.4× 185 1.3× 63 1.4k
Mounir Ait‐Khaled United Kingdom 21 1.2k 0.6× 991 0.5× 486 1.2× 117 0.6× 267 1.9× 54 1.5k
Siobhan O’Shea United Kingdom 26 1.1k 0.5× 672 0.4× 794 2.0× 88 0.5× 153 1.1× 62 1.7k

Countries citing papers authored by Bernard Masquelier

Since Specialization
Citations

This map shows the geographic impact of Bernard Masquelier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Masquelier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Masquelier more than expected).

Fields of papers citing papers by Bernard Masquelier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Masquelier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Masquelier. The network helps show where Bernard Masquelier may publish in the future.

Co-authorship network of co-authors of Bernard Masquelier

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Masquelier. A scholar is included among the top collaborators of Bernard Masquelier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Masquelier. Bernard Masquelier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armenia, Daniele, Isabelle Malet, Lavinia Fabeni, et al.. (2011). Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen. Antiviral Therapy. 16(4). 1 indexed citations
2.
Recordon-Pinson, Patrícia, Bernard Masquelier, Charles Cazanave, et al.. (2011). Molecular Characterization of Non-B HIV Type 1 Isolates from Patients of a Department of Infectious Diseases, University Hospital of Bordeaux, France, 1989–2009. AIDS Research and Human Retroviruses. 28(9). 1124–1130. 1 indexed citations
3.
Malet, Isabelle, Marc Wirden, Slim Fourati, et al.. (2011). Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients. Journal of Antimicrobial Chemotherapy. 66(7). 1481–1483. 16 indexed citations
4.
Reigadas, Sandrine, Guerric Anies, Bernard Masquelier, et al.. (2010). The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions. PLoS ONE. 5(4). e10311–e10311. 27 indexed citations
5.
Wesenbeeck, Liesbeth Van, Dominique Breilh, Guerric Anies, et al.. (2010). HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. Journal of Antimicrobial Chemotherapy. 65(6). 1262–1269. 54 indexed citations
6.
Chaix, Marie‐Laure, Diane Descamps, Marc Wirden, et al.. (2009). Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France. AIDS. 23(6). 717–724. 64 indexed citations
7.
Jauvin, Valérie, et al.. (2008). First Observation of HIV Type 1 Drug Resistance Mutations in Algeria. AIDS Research and Human Retroviruses. 24(11). 1467–1473. 3 indexed citations
8.
Masquelier, Bernard, Diane Descamps, Laurence Bocket, et al.. (2008). Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir. Journal of Antimicrobial Chemotherapy. 61(6). 1362–1368. 13 indexed citations
9.
Masquelier, Bernard, et al.. (2007). HIV Type 1 Drug Resistance among Naive Patients from Venezuela. AIDS Research and Human Retroviruses. 23(3). 482–485. 8 indexed citations
10.
Deshpande, Alaka, Valérie Jauvin, Noël Magnin, et al.. (2007). Resistance Mutations in Subtype C HIV Type 1 Isolates from Indian Patients of Mumbai Receiving NRTIs Plus NNRTIs and Experiencing a Treatment Failure: Resistance to AR. AIDS Research and Human Retroviruses. 23(2). 335–340. 49 indexed citations
11.
Costagliola, Dominique, Diane Descamps, Lambert Assoumou, et al.. (2007). Prevalence of HIV-1 Drug Resistance in Treated Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 12–18. 40 indexed citations
12.
Fleury, Hervé, Thomas d’Aquin Toni, Phạm Văn Hưng, et al.. (2006). Susceptibility to Antiretroviral Drugs of CRF01_AE, CRF02_AG, and Subtype C Viruses from Untreated Patients of Africa and Asia: Comparative Genotypic and Phenotypic Data. AIDS Research and Human Retroviruses. 22(4). 357–366. 32 indexed citations
13.
Toni, Thomas d’Aquin, Christiane Adjé-Touré, Nicole Vidal, et al.. (2005). Presence of CRF09_cpx and Complex CRF02_AG/CRF09_cpx Recombinant HIV Type 1 Strains in Côte d'Ivoire, West Africa. AIDS Research and Human Retroviruses. 21(7). 667–672. 12 indexed citations
14.
Toni, Thomas d’Aquin, Bernard Masquelier, Estibaliz Lazaro, et al.. (2005). Characterization of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Côte d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission. AIDS Research and Human Retroviruses. 21(12). 1031–1034. 20 indexed citations
15.
Toni, Thomas d’Aquin, Patrícia Recordon-Pinson, Albert Minga, et al.. (2003). Presence of Key Drug Resistance Mutations in Isolates from Untreated Patients of Abidjan, Côte d'Ivoire: ANRS 1257 Study. AIDS Research and Human Retroviruses. 19(8). 713–717. 34 indexed citations
16.
Fleury, Hervé, Patrícia Recordon-Pinson, Anne Caumont, et al.. (2003). HIV Type 1 Diversity in France, 1999–2001: Molecular Characterization of non-B HIV Type 1 Subtypes and Potential Impact on Susceptibility to Antiretroviral Drugs. AIDS Research and Human Retroviruses. 19(1). 41–47. 41 indexed citations
17.
Fleury, Hervé, Patrícia Recordon-Pinson, Muriel Faure, Bernard Masquelier, & M. Dupon. (2003). HIV-1 transmission during scintigraphy. The Lancet. 362(9379). 210–210. 9 indexed citations
18.
Descamps, Diane, Vincent Cálvez, Jacques Izopet, et al.. (2001). Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. AIDS. 15(14). 1777–1782. 30 indexed citations
19.
Lang, Dieter, Walter Hinderer, H.‐H. Sonneborn, et al.. (1999). Comparison of the Immunoglobulin-G-Specific Seroreactivity of Different Recombinant Antigens of the Human Herpesvirus 8. Virology. 260(1). 47–54. 28 indexed citations
20.
Beylot‐Barry, M., B. Vergier, Bernard Masquelier, et al.. (1999). The Spectrum of Cutaneous Lymphomas in HIV Infection. The American Journal of Surgical Pathology. 23(10). 1208–1208. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. M. A. Lange Breakdown of academic impact, for papers by Diane Descamps Breakdown of academic impact, for papers by Leslie Jonas Breakdown of academic impact, for papers by S Cassol Breakdown of academic impact, for papers by Laurence Morand‐Joubert Breakdown of academic impact, for papers by Gilles Collin Breakdown of academic impact, for papers by Alain Lafeuillade Breakdown of academic impact, for papers by Sidonie Lambert-Niclot Breakdown of academic impact, for papers by Mounir Ait‐Khaled Breakdown of academic impact, for papers by Siobhan O’Shea
Rankless by CCL
2026